首页> 外文期刊>Marine biotechnology >Modulation of Lipid Metabolism by Deep-Sea Water in Cultured Human Liver (HepG2) Cells
【24h】

Modulation of Lipid Metabolism by Deep-Sea Water in Cultured Human Liver (HepG2) Cells

机译:深海水在培养的人肝(HepG2)细胞中对脂质代谢的调节

获取原文
获取原文并翻译 | 示例
           

摘要

It has been found that deep-sea water was associated with lower serum lipid in animal model studies. Herein, we investigated whether DSW exerted a hypolipidemic activity and further elucidated how DSW modulated lipid metabolism in HepG2 cells. Preliminary animal studies showed that DSW exhibited potency to decrease serum total cholesterol, triglycerides, and LDL cholesterol, and increase HDL cholesterol, and the hepatic lipid contents were also significantly lower in the DSW group. When DSW was added to HepG2 cells, it decreased the lipid contents of hepatocyte through the activation of AMP-activated protein kinase, thus inhibiting the synthesis of cholesterol and fatty acid. Besides, LDL receptor was upregulated by activation of sterol regulatory element-binding protein-2. In addition, the levels of apolipoprotein AI and cholesterol 7-alpha-hydroxylase were also raised. Our investigation provided mechanisms by which DSW modulated lipid metabolism and indicated that DSW was worthy of further investigation and could be developed as functional drinking water in the prevention and treatment of hypolipidemic and other lifestyle-related diseases.
机译:在动物模型研究中发现深海水与较低的血脂有关。在这里,我们调查了DSW是否发挥降血脂活性,并进一步阐明了DSW如何调节HepG2细胞中的脂质代谢。初步的动物研究表明,DSW组具有降低血清总胆固醇,甘油三酸酯和LDL胆固醇,增加HDL胆固醇的功效,并且DSW组的肝脂质含量也显着降低。将DSW加入HepG2细胞后,它会通过激活AMP激活的蛋白激酶来降低肝细胞的脂质含量,从而抑制胆固醇和脂肪酸的合成。此外,LDL受体通过激活固醇调节元件结合蛋白2上调。另外,载脂蛋白AI和胆固醇7-α-羟化酶的水平也升高。我们的研究提供了DSW调节脂质代谢的机制,并表明DSW值得进一步研究,可以作为功能性饮用水用于预防和治疗降血脂和其他与生活方式有关的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号